FDA's Pazdur: I Won't Turn Into A Bureaucrat; My Presence Will Be Felt
Executive Summary
Richard Pazdur, who is moving from being the head of the FDA's Office of Hematology and Oncology Products (OHOP) to the agency's acting director of the newly created Oncology Center of Excellence, established under the White House's National Cancer Moonshot initiative, sat down with reporters on June 29 to explain his new role, but warned don't think he's just going to turn into some sort of a bureaucrat and to anticipate his presence to continue to very much be felt at OHOP.